Evofem Biosciences, Inc., (NASDAQ: EVFM) is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (STIs). The Company's first commercial product, Phexxi®, is the first and only hormone-free, prescription vaginal gel approved in the United States for the prevention of pregnancy. The Company’s lead product candidate, EVO100, is being evaluated for the prevention of urogenital Chlamydia trachomatis and Neisseria gonorrhoeae infection in women in the ongoing Phase 3 clinical trial, ‘EVOGUARD.’

Biotechnology

Evofem Biosciences

Evofem Biosciences' headquarters in San Diego, CA, United States

Saundra Pelletier

Amy Raskopf

Ivy Zhang

Kathy Gallo-Doyle

Ellen Thomas

Richard Murawski

Robin Belsaas

Catherine Maher

Tony O’Brien

Kim Kamdar

Lisa Rarick

Colin Rutherford

Description

People (9)

Saundra Pelletier

Ellen Thomas

Richard Murawski

Ivy Zhang

David Friend

Danielle M. Adams

Jennifer R.

Steve Myers

Katie Siegmund

Jobs